In leukemia, DMAMCL induces cell death by inhibiting the NF-κB pathway [28], whereas DMAMCL induces apoptosis in osteosarcoma by activating caspase-dependent pathways [55] and inactivates the PI3K/Akt pathway in HCC [27]. The gene discussed is AKT1; the disease is osteosarcoma.